Andrew Worland – Managing Director and Chief Executive Officer – International Graphite (ASX:IG6) is building Australia’s capability in critical battery minerals and establishing a new ethical supply of battery anode graphite to support the global revolution in clean energy.
Copyright 2023 – Finance News Network
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
09 Feb 2023 - Sequoia Asset Management Investment Manager Winston Sammut discusses property investment strategy, the impacts of COVID and work from home, shopping malls, industrial property, and alternative property classes.
07 Jun 2021 - Peel Mining Limited (ASX:PEX) Managing Director Rob Tyson talks about the company's projects targeting zinc & copper, drill results, hub and spoke model, and its outlook.
27 Jun 2022 - North Stawell Minerals Limited (ASX:NSM) CEO Russell Krause discusses recent drilling results, plans through the winter months, and outlook.
23 Feb 2024 - Discover Sunshine Metals' strategic focus on Queensland's prolific gold and base metal districts, unveiling promising exploration ventures and recent resource upgrades.
05 Dec 2019 - Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts talks about progress with the company's human assisted reproductive device for the separation of sperm cells in IVF clinics.
02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.